Trial
NCT02030314
The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Resistant Hypertension in Kidney Transplant Patients
Intervention
Chlorthalidone
Why stopped
The patient population changed. Unable to find patients that meet study criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-15